← back to search

María Angélica Cortez

The Ohio State University · US
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research focused on microRNA and Immune system, with related work in Carcinogenesis, Cancer, Immunosuppression. Notable publications include 'Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression', 'Altered cancer metabolism in mechanisms of immunotherapy resistance', and 'Role of Mitochondria in Cancer Immune Evasion and Potential Therapeutic Approaches'.
h-index
citations
1,723
works
9
NIH funding
primary concept
email

Recent publications

High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial
Radiotherapy and Oncology 2021cited by 90position: middledoi
Role of Mitochondria in Cancer Immune Evasion and Potential Therapeutic Approaches
Frontiers in Immunology 2020cited by 125position: middledoi
Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy
Journal for ImmunoTherapy of Cancer 2019cited by 123position: middledoi
Altered cancer metabolism in mechanisms of immunotherapy resistance
Pharmacology & Therapeutics 2018cited by 187position: lastdoi
Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs
Nature Communications 2018cited by 6position: middledoi
Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs
Nature Communications 2017cited by 50position: middledoi
Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
Nature Communications 2014cited by 986position: middledoi
Cellular and Kaposi’s sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma
Cell Death and Disease 2014cited by 55position: middledoi
HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts
Cell Death and Differentiation 2013cited by 101position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Hampartsoum B. Barsoumian · The University of Texas Health Science Center at Houston3 papers (2018–2020)James W. Welsh · The University of Texas MD Anderson Cancer Center3 papers (2018–2020)George A. Călin · The University of Texas MD Anderson Cancer Center2 papers (2013–2014)Manuela Ferracin · IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola2 papers (2013–2014)Ahmed Younes · Southwestern Medical Center2 papers (2019–2020)Masayoshi Shimizu · The University of Texas MD Anderson Cancer Center2 papers (2013–2014)Hari Menon · University of Wisconsin–Madison2 papers (2018–2019)Rishab Ramapriyan · Neurological Surgery2 papers (2018–2019)Massimo Negrini · The Ohio State University2 papers (2013–2014)Isabella C. Glitza · The University of Texas MD Anderson Cancer Center1 papers (2019–2019) · 1 papers (2018–2018)Jeffrey S. Morris · California University of Pennsylvania1 papers (2014–2014)Kishore B. Challagundla · Philadelphia College of Osteopathic Medicine1 papers (2014–2014)Thomas D. Schmittgen · National University of Singapore1 papers (2013–2013) · 1 papers (2013–2013)Taylor R. Cushman · University of Arizona1 papers (2019–2019) · 1 papers (2014–2014)Renata Ferrarotto · The University of Texas MD Anderson Cancer Center1 papers (2019–2019)Muller Fabbri · Children's National1 papers (2014–2014)Stephen G. Chun · The University of Texas MD Anderson Cancer Center1 papers (2019–2019)